INSPIRE MEDICAL SYSTEMS INC (INSP) Fundamental Analysis & Valuation

NYSE:INSP • US4577301090

Current stock price

50.45 USD
-0.96 (-1.87%)
At close:
50.45 USD
0 (0%)
After Hours:

This INSP fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. INSP Profitability Analysis

1.1 Basic Checks

  • INSP had positive earnings in the past year.
  • In the past year INSP had a positive cash flow from operations.
  • In multiple years INSP reported negative net income over the last 5 years.
  • Of the past 5 years INSP 4 years had a positive operating cash flow.
INSP Yearly Net Income VS EBIT VS OCF VS FCFINSP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M

1.2 Ratios

  • INSP has a better Return On Assets (16.03%) than 95.24% of its industry peers.
  • INSP has a Return On Equity of 18.62%. This is amongst the best in the industry. INSP outperforms 92.59% of its industry peers.
  • With a decent Return On Invested Capital value of 5.75%, INSP is doing good in the industry, outperforming 76.72% of the companies in the same industry.
Industry RankSector Rank
ROA 16.03%
ROE 18.62%
ROIC 5.75%
ROA(3y)6.51%
ROA(5y)-0.53%
ROE(3y)7.56%
ROE(5y)-0.94%
ROIC(3y)N/A
ROIC(5y)N/A
INSP Yearly ROA, ROE, ROICINSP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -500 -1K

1.3 Margins

  • The Profit Margin of INSP (15.95%) is better than 92.59% of its industry peers.
  • With a decent Operating Margin value of 5.59%, INSP is doing good in the industry, outperforming 70.90% of the companies in the same industry.
  • The Gross Margin of INSP (85.39%) is better than 94.71% of its industry peers.
  • In the last couple of years the Gross Margin of INSP has remained more or less at the same level.
Industry RankSector Rank
OM 5.59%
PM (TTM) 15.95%
GM 85.39%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.64%
GM growth 5Y0.15%
INSP Yearly Profit, Operating, Gross MarginsINSP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. INSP Health Analysis

2.1 Basic Checks

  • INSP has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • INSP has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, INSP has more shares outstanding
  • INSP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
INSP Yearly Shares OutstandingINSP Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
INSP Yearly Total Debt VS Total AssetsINSP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • INSP has an Altman-Z score of 8.47. This indicates that INSP is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 8.47, INSP belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
  • There is no outstanding debt for INSP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 8.47
ROIC/WACC0.54
WACC10.59%
INSP Yearly LT Debt VS Equity VS FCFINSP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

  • INSP has a Current Ratio of 6.08. This indicates that INSP is financially healthy and has no problem in meeting its short term obligations.
  • INSP has a better Current ratio (6.08) than 79.89% of its industry peers.
  • A Quick Ratio of 4.56 indicates that INSP has no problem at all paying its short term obligations.
  • INSP has a Quick ratio of 4.56. This is in the better half of the industry: INSP outperforms 78.31% of its industry peers.
Industry RankSector Rank
Current Ratio 6.08
Quick Ratio 4.56
INSP Yearly Current Assets VS Current LiabilitesINSP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. INSP Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 45.09% over the past year.
  • INSP shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.60%.
  • INSP shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 51.20% yearly.
EPS 1Y (TTM)45.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.87%
Revenue 1Y (TTM)13.6%
Revenue growth 3Y30.76%
Revenue growth 5Y51.2%
Sales Q2Q%12.25%

3.2 Future

  • The Earnings Per Share is expected to grow by 18.33% on average over the next years. This is quite good.
  • Based on estimates for the next years, INSP will show a quite strong growth in Revenue. The Revenue will grow by 9.35% on average per year.
EPS Next Y-21.33%
EPS Next 2Y1.51%
EPS Next 3Y12.02%
EPS Next 5Y18.33%
Revenue Next Year6.52%
Revenue Next 2Y7.48%
Revenue Next 3Y8.46%
Revenue Next 5Y9.35%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
INSP Yearly Revenue VS EstimatesINSP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B
INSP Yearly EPS VS EstimatesINSP Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 2 -2 4 -4 6

More info and screens

Find the best growth stocksShow best growing peers

5

4. INSP Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 20.10, the valuation of INSP can be described as rather expensive.
  • 80.42% of the companies in the same industry are more expensive than INSP, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 25.23, INSP is valued a bit cheaper.
  • The Price/Forward Earnings ratio is 25.55, which means the current valuation is very expensive for INSP.
  • Based on the Price/Forward Earnings ratio, INSP is valued a bit cheaper than the industry average as 74.07% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of INSP to the average of the S&P500 Index (22.51), we can say INSP is valued inline with the index average.
Industry RankSector Rank
PE 20.1
Fwd PE 25.55
INSP Price Earnings VS Forward Price EarningsINSP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of INSP indicates a somewhat cheap valuation: INSP is cheaper than 79.89% of the companies listed in the same industry.
  • INSP's Price/Free Cash Flow ratio is rather cheap when compared to the industry. INSP is cheaper than 90.48% of the companies in the same industry.
Industry RankSector Rank
P/FCF 18.38
EV/EBITDA 14.34
INSP Per share dataINSP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • INSP has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as INSP's earnings are expected to grow with 12.02% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.51%
EPS Next 3Y12.02%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. INSP Dividend Analysis

5.1 Amount

  • INSP does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

INSP Fundamentals: All Metrics, Ratios and Statistics

INSPIRE MEDICAL SYSTEMS INC

NYSE:INSP (3/26/2026, 8:04:00 PM)

After market: 50.45 0 (0%)

50.45

-0.96 (-1.87%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-11
Earnings (Next)05-04
Inst Owners120.91%
Inst Owner Change9.03%
Ins Owners1.39%
Ins Owner Change2.32%
Market Cap1.44B
Revenue(TTM)911.98M
Net Income(TTM)145.42M
Analysts73.6
Price Target95.55 (89.4%)
Short Float %13.48%
Short Ratio2.86
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)176.52%
Min EPS beat(2)81.33%
Max EPS beat(2)271.71%
EPS beat(4)4
Avg EPS beat(4)151.77%
Min EPS beat(4)81.33%
Max EPS beat(4)271.71%
EPS beat(8)8
Avg EPS beat(8)214.54%
EPS beat(12)12
Avg EPS beat(12)205.03%
EPS beat(16)16
Avg EPS beat(16)165.1%
Revenue beat(2)0
Avg Revenue beat(2)-0.44%
Min Revenue beat(2)-0.7%
Max Revenue beat(2)-0.17%
Revenue beat(4)1
Avg Revenue beat(4)-0.11%
Min Revenue beat(4)-0.7%
Max Revenue beat(4)1.13%
Revenue beat(8)3
Avg Revenue beat(8)0.06%
Revenue beat(12)6
Avg Revenue beat(12)1.03%
Revenue beat(16)10
Avg Revenue beat(16)3.19%
PT rev (1m)-27.11%
PT rev (3m)-25.42%
EPS NQ rev (1m)-202.81%
EPS NQ rev (3m)-378.12%
EPS NY rev (1m)12.01%
EPS NY rev (3m)13.22%
Revenue NQ rev (1m)-1.59%
Revenue NQ rev (3m)-5.54%
Revenue NY rev (1m)-0.46%
Revenue NY rev (3m)-4.39%
Valuation
Industry RankSector Rank
PE 20.1
Fwd PE 25.55
P/S 1.58
P/FCF 18.38
P/OCF 12.33
P/B 1.85
P/tB 1.85
EV/EBITDA 14.34
EPS(TTM)2.51
EY4.98%
EPS(NY)1.97
Fwd EY3.91%
FCF(TTM)2.74
FCFY5.44%
OCF(TTM)4.09
OCFY8.11%
SpS31.9
BVpS27.32
TBVpS27.32
PEG (NY)N/A
PEG (5Y)N/A
Graham Number39.28
Profitability
Industry RankSector Rank
ROA 16.03%
ROE 18.62%
ROCE 6.28%
ROIC 5.75%
ROICexc 9.27%
ROICexgc 9.27%
OM 5.59%
PM (TTM) 15.95%
GM 85.39%
FCFM 8.61%
ROA(3y)6.51%
ROA(5y)-0.53%
ROE(3y)7.56%
ROE(5y)-0.94%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.64%
GM growth 5Y0.15%
F-Score7
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 275.84%
Cap/Sales 4.22%
Interest Coverage 371.93
Cash Conversion 180.21%
Profit Quality 53.97%
Current Ratio 6.08
Quick Ratio 4.56
Altman-Z 8.47
F-Score7
WACC10.59%
ROIC/WACC0.54
Cap/Depr(3y)567.8%
Cap/Depr(5y)515.09%
Cap/Sales(3y)4.29%
Cap/Sales(5y)3.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)45.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.87%
EPS Next Y-21.33%
EPS Next 2Y1.51%
EPS Next 3Y12.02%
EPS Next 5Y18.33%
Revenue 1Y (TTM)13.6%
Revenue growth 3Y30.76%
Revenue growth 5Y51.2%
Sales Q2Q%12.25%
Revenue Next Year6.52%
Revenue Next 2Y7.48%
Revenue Next 3Y8.46%
Revenue Next 5Y9.35%
EBIT growth 1Y41.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year683.86%
EBIT Next 3Y109.9%
EBIT Next 5Y69.99%
FCF growth 1Y-13.88%
FCF growth 3Y216.73%
FCF growth 5YN/A
OCF growth 1Y-10.19%
OCF growth 3Y116.23%
OCF growth 5YN/A

INSPIRE MEDICAL SYSTEMS INC / INSP Fundamental Analysis FAQ

What is the ChartMill fundamental rating of INSPIRE MEDICAL SYSTEMS INC (INSP) stock?

ChartMill assigns a fundamental rating of 6 / 10 to INSP.


Can you provide the valuation status for INSPIRE MEDICAL SYSTEMS INC?

ChartMill assigns a valuation rating of 5 / 10 to INSPIRE MEDICAL SYSTEMS INC (INSP). This can be considered as Fairly Valued.


How profitable is INSPIRE MEDICAL SYSTEMS INC (INSP) stock?

INSPIRE MEDICAL SYSTEMS INC (INSP) has a profitability rating of 6 / 10.


What are the PE and PB ratios of INSPIRE MEDICAL SYSTEMS INC (INSP) stock?

The Price/Earnings (PE) ratio for INSPIRE MEDICAL SYSTEMS INC (INSP) is 20.1 and the Price/Book (PB) ratio is 1.85.


What is the financial health of INSPIRE MEDICAL SYSTEMS INC (INSP) stock?

The financial health rating of INSPIRE MEDICAL SYSTEMS INC (INSP) is 8 / 10.